The role of C5a in hypersensitivity reactions in the lung.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Pulmonary Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0952-0600(89)80003-1PMID 2520486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Absence of inflammatory lung injury in rabbits challenged intravascularly with complement-derived chemotactic factors.

  2015cited by this paper
• Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg.

  1988cited by this paper
• Identification of the C5a des Arg cochemotaxin. Homology with vitamin D-binding protein (group-specific component globulin).

  1988cited by this paper
• Human C5a induces a substantial histamine release in human basophils but not in tissue mast cells.

  1988cited by this paper
• Role of arachidonate metabolites in C5a-induced bronchoconstriction.

  1988cited by this paper
• A direct in vivo comparison of the inflammatory properties of human C5a and C5a des Arg in human skin.

  1988cited by this paper
• Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release.

  1988cited by this paper
• C5a-induced bronchoconstriction: absence of a role of circulating white blood cells and platelets.

  1988cited by this paper
• Mediators of C5a-induced bronchoconstriction in the guinea pig.

  1987cited by this paper
• Perspectives in platelet-activating factor research.

  1987cited by this paper
• The properties of human C5a anaphylatoxin. The significance of C5a formation during hemodialysis.

  1987cited by this paper
• AIRWAY RESPONSES IN VITRO FOLLOWING C5A DES ARG‐INDUCED HYPER‐RESPONSIVENESS IN VIVO IN RABBITS

  1987cited by this paper
• Biochemistry and biology of anaphylatoxins.

  1986cited by this paper
• Airways hyperreactivity and inflammation produced by aerosolization of human C5A des arg.

  1986cited by this paper
• Modulation of the immune response by anaphylatoxins.

  1986cited by this paper
• Indomethacin inhibits the increased airway responsiveness to histamine following inhalation of C5a des Arg in rabbits

  1986cited by this paper
• Chemical synthesis of a gene encoding the human complement fragment C5a and its expression in Escherichia coli.

  1985cited by this paper
• Additive effect of intravascular complement activation and brief episodes of hypoxia in producing increased permeability in the rabbit lung.

  1985cited by this paper
• Anaphylatoxin C3a enhances mucous glycoprotein release from human airways in vitro

  1985cited by this paper
• Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.

  1985cited by this paper
• Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo.

  1985cited by this paper
• Effects of a thromboxane synthetase inhibitor and a thromboxane antagonist on release and activity of thromboxane A2 and prostacyclin in vitro.

  1985cited by this paper
• Leukotriene-induced contraction and thromboxane production in guinea-pig lung parenchymal strips.

  1984cited by this paper
• Spasmogenic activity of C5adesArg anaphylatoxin on guinea pig lung parenchymal strips: sensitivity of the leukotriene-mediated component to cyclooxygenase inhibitors.

  1984cited by this paper
• Immunoglobulin G- and immunoglobulin E-mediated airway smooth muscle contraction in the guinea pig.

  1984cited by this paper
• The effect of indomethacin on the contractile response of the guinea‐pig lung parenchymal strip to leukotrienes B4, C4, D4 and E4

  1983cited by this paper
• Sodium 5-(3'-pyridinylmethyl)benzofuran-2-carboxylate (U-63557A), a new, selective thromboxane synthase inhibitor: intravenous and oral pharmacokinetics in dogs and correlations with ex situ thromboxane B2 production.

  1983cited by this paper
• Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase.

  1983cited by this paper
• C5a-induced histamine release. Species specificity.

  1983cited by this paper
• C5a and antigen-induced tracheal contraction: effect of a combination of an antihistamine and cyclo-oxygenase inhibitors.

  1983cited by this paper
• Bronchoconstrictor effects of leukotriene B4 in the guinea pig in vivo.

  1983cited by this paper
• Effects of C5a on guinea pig lung: histamine release and mechanism of contraction.

  1983cited by this paper
• Generation of biologically active, complement-(C5) derived peptides by cathepsin H.

  1983cited by this paper
• The absence of detectable complement activation in aspirin-sensitive asthmatic patients during aspirin challenge.

  1983cited by this paper
• Plasma histamine concentrations and complement activation during house dust mite‐provoked bronchia] obstructive reactions

  1983cited by this paper
• Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments

  1983cited by this paper
• Relaxation of the guinea-pig trachea induced by platelet-activating factor and by serotonin.

  1982cited by this paper
• Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites.

  1982cited by this paper
• In vitro and in vivo mechanisms of leukotriene-mediated bronchoconstriction in the guinea pig.

  1982cited by this paper
• Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin.

  1982cited by this paper
• The activation of the alternative pathway C3 convertase by human plasma kallikrein.

  1982cited by this paper
• Anaphylatoxin-mediated contraction of guinea pig lung strips: a nonhistamine tissue response.

  1981cited by this paper
• Inhibition of antigen-induced histamine release and thromboxane synthase by FPL 55712, a specific SRA-A antagonist?

  1981cited by this paper
• C5a-induced tracheal contraction: effect of an SRS-A antagonist and inhibitors of arachidonate metabolism.

  1981cited by this paper
• Platelet-serotonin release by C3a and C5a: two independent pathways of activation.

  1981cited by this paper
• Human C5a des Arg increases vascular permeability.

  1981cited by this paper
• The lung parenchymal strip: a reappraisal.

  1981cited by this paper
• Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.

  1981cited by this paper
• Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit

  1981cited by this paper
• Purification of the third and fifth components of human complement: application of hydrophobic chromatography.

  1980cited by this paper
• A differential effect of C5a and C5a des Arg in the induction of pulmonary inflammation.

  1980cited by this paper
• Lung inflammation induced by complement-derived chemotactic fragments in the alveolus.

  1980cited by this paper
• Pulmonary injury induced by C3a and C5a anaphylatoxins.

  1980cited by this paper
• Quantitative comparisons of neutrophil chemotaxis in four animal species.

  1980cited by this paper
• C5a induced tracheal contraction: a histamine independent mechanism.

  1980cited by this paper
• In vitro studies of antigen-induced bronchospasm: effect of antihistamine and SRS-A antagonist on response of sensitized guinea pig and human airways to antigen.

  1979cited by this paper
• Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.

  1978cited by this paper
• Comparative responses of tracheal spirals and parenchymal strips to histamine and carbachol in vitro.

  1978cited by this paper
• Changes of serum complement and eosinophil count in antigen induced bronchospasm.

  1978cited by this paper
• Levels of complement components during allergen‐induced asthma

  1978cited by this paper
• Changes of serum complement and eosinophil count in antigen induced bronchospasm.

  1978cited by this paper
• Anaphylatoxins: C3a and C5a.

  1978cited by this paper
• Plasma complement changes during bronchospasm provoked in asthmatic patients *

  1977cited by this paper
• Induction of platelet aggregation by the complement-derived peptides C3a and C5a

  1976cited by this paper
• Effect of hog anaphylatoxin (C5a) on vascular permeability and leukocyte emigration in vivo

  1976cited by this paper
• Complement-induced histamine release from human basophils. I. Generation of activity in human serum.

  1975cited by this paper
• Release of histamine from rat mast cells by the complement peptides C3a and C5a.

  1975cited by this paper
• Atropine modification of the pulmonary effects of chemical mediators in the guinea pig.

  1975cited by this paper
• Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity.

  1975cited by this paper
• Contractile responses of the guinea-pig trachea in vitro: modification by prostaglandin synthesis-inhibiting drugs.

  1975cited by this paper
• Changes in arteriovenous complement activity induced by inhalation challenge.

  1973cited by this paper
• Selective inhibitor of slow reacting substance of anaphylaxis.

  1973cited by this paper
• Airway dilatation and constriction in spontaneously breathing guinea pigs.

  1972cited by this paper
• AN EOSINOPHIL LEUKOCYTE CHEMOTACTIC FACTOR OF ANAPHYLAXIS

  1971cited by this paper
• Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes.

  1970cited by this paper
• A PLASMIN-SPLIT FRAGMENT OF C'3 AS A NEW CHEMOTACTIC FACTOR

  1967cited by this paper
• Actions of anaphylatoxin on circulation and respiration of the guinea pig.

  1967cited by this paper
• STUDIES ON THE MECHANISM OF HYPERSENSITIVITY PHENOMENA

  1959cited by this paper

• Other Mediators of Airway Disease

  2002cites this paper
• Effect of nedocromil sodium on microvascular leakage.

  1993cites this paper